KidneyCure
Tel Aviv
About KidneyCure
KidneyCure Ltd. is developing proprietary cell therapies aiming to prevent progression of Chronic Kidney Disease. The scientific basis and motivation for KidneyCure’s approach was provided by a world-renowned authority in Nephrology Prof. Benjamin Dekel, through genuinely pioneering research carried in his laboratory at Sheba Medical Center in Israel, one of the world’s leading medical centers. KidneyCure’s unique 3D renal cell cluster technology is expected to significantly delay the need for dialysis and transplantation and give millions of patients an opportunity to live longer higher quality lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Last round: Series Unknown (Nov 2018)
- Website: kidneycure.com
- Phone: +972-54-453-4340
Industries & Categories
Biotechnology, Clinical Trials
Canonical: https://fsome.com/organization/kidneycure-95791 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.